Catalyst
Slingshot members are tracking this event:
Tesaro (TSRO) to Initiate Phase 1 Trial in Mid-2017 Evaluating TSR-022 in Combination with an Anti-PD-1 mAb in Various Tumor Types
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TSRO |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 08, 2017
Occurred Source:
http://ir.tesarobio.com/releasedetail.cfm?ReleaseID=1036568
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1, Phase 1 Initiation, Tsr-022, Various Tumor Types, Anti-pd-1 Mab
